These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15355662)

  • 1. [The predictive value of risk scoring system in myocardial infarction in long-term prognosis of patients referred to direct percutaneous coronary intervention].
    Zhao MZ; Hu DY; Li WH; Chen XY; Xu YY
    Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):584-7. PubMed ID: 15355662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of hemoglobin levels on long-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Jin XF; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Liu ZY; Xie HZ
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(42):3003-6. PubMed ID: 22333029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Damman P; Woudstra P; Kuijt WJ; Kikkert WJ; van de Hoef TP; Grundeken MJ; Harskamp RE; Henriques JP; Piek JJ; Tijssen JG; de Winter RJ
    J Interv Cardiol; 2013 Feb; 26(1):8-13. PubMed ID: 22971136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Uyarel H; Ayhan E; Cicek G; Isik T; Ugur M; Bozbay M; Yildirim E; Ergelen M; Eren M
    Coron Artery Dis; 2012 Mar; 23(2):98-104. PubMed ID: 22318130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of left ventricular ejection fraction on clinical long-term follow-up outcomes in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Wang CH; Xie XJ; Fang Q; Zhang SY; Fang ZJ; Jiang XF; Xie HZ; Liu ZY; Shen ZJ
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):265-8. PubMed ID: 21418873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ; Hendel RC; Nathan S; Meyer PM; Calvin JE; Klein LW
    J Invasive Cardiol; 2003 Sep; 15(9):502-6. PubMed ID: 12947210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new post-PCI scoring system for in-hospital mortality in STEMI patients.
    Chiostri M; Valente S; Crudeli E; Giglioli C; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):733-8. PubMed ID: 20479658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TIMI risk score for STEMI predicts in-hospital mortality and adverse events in patients without cardiogenic shock undergoing primary angioplasty.
    González-Pacheco H; Arias-Mendoza A; Álvarez-Sangabriel A; Juárez-Herrera Ú; Damas F; Eid-Lidt G; Azar-Manzur F; Martínez-Sánchez C
    Arch Cardiol Mex; 2012; 82(1):7-13. PubMed ID: 22452860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation of serum uric acid levels with coronary flow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention].
    Wang JW; Chen YD; Wang CH; Zhu XL
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(44):3100-3. PubMed ID: 23328417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes.
    Dudek D; Mielecki W; Wizimirski M; Rakowski T; Dziewierz A; Sorysz D; Tomala M; Zorkun C; Zmudka K; Dubiel JS
    Kardiol Pol; 2004 Sep; 61(9):232-41; discussion 242. PubMed ID: 15531935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].
    Ji C; Song F; Huang X; Qu X; Qiu N; Zhu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Mar; 35(3):299-304. PubMed ID: 36916344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
    Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
    Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
    Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the myocardial blush grade scored by the operator during primary percutaneous coronary intervention of prognostic value in patients with ST-elevation myocardial infarction in routine clinical practice?
    Kampinga MA; Nijsten MW; Gu YL; Dijk WA; de Smet BJ; van den Heuvel AF; Tan ES; Zijlstra F
    Circ Cardiovasc Interv; 2010 Jun; 3(3):216-23. PubMed ID: 20442359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Values of matrix metalloproteinase-9 in early diagnosis and short-term prognosis of ST-segment elevation myocardial infarction].
    Guo JL; Yang YN; Ma YT; Li XM; Sun HP; Xie X; Liu F
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2681-4. PubMed ID: 23290105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.